Literature DB >> 18380339

Relating alternative splicing to proteome complexity and genome evolution.

Yi Xing1, Christopher Lee.   

Abstract

Prior to genomics, studies of alternative splicing primarily focused on the function and mechanism of alternative splicing in individual genes and exons. This has changed dramatically since the late 1990s. High-throughput genomics technologies, such as EST sequencing and microarrays designed to detect changes in splicing, led to genome-wide discoveries and quantification of alternative splicing in a wide range of species from human to Arabidopsis. Consensus estimates of AS frequency in the human genome grew from less than 5% in mid-1990s to as high as 60-74% now. The rapid growth in sequence and microarray data for alternative splicing has made it possible to look into the global impact of alternative splicing on protein function and evolution of genomes. In this chapter, we review recent research on alternative splicing's impact on proteomic complexity and its role in genome evolution.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18380339     DOI: 10.1007/978-0-387-77374-2_3

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  18 in total

1.  An antisense microwalk reveals critical role of an intronic position linked to a unique long-distance interaction in pre-mRNA splicing.

Authors:  Natalia N Singh; Katrin Hollinger; Dhruva Bhattacharya; Ravindra N Singh
Journal:  RNA       Date:  2010-04-22       Impact factor: 4.942

2.  TIA1 prevents skipping of a critical exon associated with spinal muscular atrophy.

Authors:  Natalia N Singh; Joonbae Seo; Eric W Ottesen; Maria Shishimorova; Dhruva Bhattacharya; Ravindra N Singh
Journal:  Mol Cell Biol       Date:  2010-12-28       Impact factor: 4.272

Review 3.  Alternative splicing and the evolution of phenotypic novelty.

Authors:  Stephen J Bush; Lu Chen; Jaime M Tovar-Corona; Araxi O Urrutia
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-02-05       Impact factor: 6.237

4.  Distinct regulatory programs establish widespread sex-specific alternative splicing in Drosophila melanogaster.

Authors:  Britta Hartmann; Robert Castelo; Belén Miñana; Erin Peden; Marco Blanchette; Donald C Rio; Ravinder Singh; Juan Valcárcel
Journal:  RNA       Date:  2011-01-13       Impact factor: 4.942

5.  Mitogen-activated protein kinase phosphorylation of splicing factor 45 (SPF45) regulates SPF45 alternative splicing site utilization, proliferation, and cell adhesion.

Authors:  Adnan M Al-Ayoubi; Hui Zheng; Yuying Liu; Tao Bai; Scott T Eblen
Journal:  Mol Cell Biol       Date:  2012-05-21       Impact factor: 4.272

6.  HMGA1a trapping of U1 snRNP at an authentic 5' splice site induces aberrant exon skipping in sporadic Alzheimer's disease.

Authors:  Kenji Ohe; Akila Mayeda
Journal:  Mol Cell Biol       Date:  2010-03-01       Impact factor: 4.272

7.  An overview of the introns-first theory.

Authors:  David Penny; Marc P Hoeppner; Anthony M Poole; Daniel C Jeffares
Journal:  J Mol Evol       Date:  2009-09-24       Impact factor: 2.395

8.  A short antisense oligonucleotide masking a unique intronic motif prevents skipping of a critical exon in spinal muscular atrophy.

Authors:  Natalia N Singh; Maria Shishimorova; Lu Cheng Cao; Laxman Gangwani; Ravindra N Singh
Journal:  RNA Biol       Date:  2009-07-14       Impact factor: 4.652

9.  Antisense oligonucleotide mediated therapy of spinal muscular atrophy.

Authors:  Senthilkumar Sivanesan; Matthew D Howell; Christine J Didonato; Ravindra N Singh
Journal:  Transl Neurosci       Date:  2013-03       Impact factor: 1.757

10.  Predicting functional alternative splicing by measuring RNA selection pressure from multigenome alignments.

Authors:  Hongchao Lu; Lan Lin; Seiko Sato; Yi Xing; Christopher J Lee
Journal:  PLoS Comput Biol       Date:  2009-12-18       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.